Evidence map›Paper›PMID 42665410›Full record

ArticleIn vivo (Athens, Greece)

Hereditary Diffuse Gastric Cancer With Poorly Differentiated Gallbladder Adenocarcinoma: A Case Report Suggesting Carcinogenesis in the Stomach and Gallbladder Caused by a Pathogenic Germline Variant in

Masato Hayashi, Naoto Kubota, Makoto Abe, Masatsugu Ishii, Kazuki Sasaki, Miho Ando, Kokichi Sugano, Teruhiko Yoshida, Makoto Hirata, Haruhiko Sugimura

Abstract readCase Reports
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masato HayashiDepartment of Surgery, Tochigi Cancer Center, Tochigi, Japan; sas.jtf@gmail.com.
Naoto KubotaTochigi Cancer Center Research Institute, Tochigi, Japan.
Makoto AbeTochigi Cancer Center Research Institute, Tochigi, Japan.
Masatsugu IshiiDepartment of Surgery, Tochigi Cancer Center, Tochigi, Japan.
Kazuki SasakiTochigi Cancer Center Research Institute, Tochigi, Japan.
Miho AndoDepartment of Cancer Prevention and Genetic Testing, Genome Center, Tochigi Cancer Center, Tochigi, Japan.
Kokichi SuganoDepartment of Cancer Prevention and Genetic Testing, Genome Center, Tochigi Cancer Center, Tochigi, Japan.
Teruhiko YoshidaDepartment of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
Makoto HirataDepartment of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
Haruhiko SugimuraDirector, Kyoundo Hospital, Sasaki Foundation, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimHereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome primarily characterized by a high lifetime risk of diffuse gastric cancer and lobular breast cancer. It is predominantly caused by inactivating germline variants in the tumor suppressor gene CASE REPORT: We present the case of a 67-year-old female initially referred for surgical management of gallbladder cancer (GBC) following an initial cholecystectomy for progressive wall thickening. Pathological examination of the gallbladder revealed a de novo, poorly differentiated adenocarcinoma invading the subserosal layer with reduced E-cadherin expression. Given the atypical histopathology and a significant family history-her father and brother both died of gastric cancer at young ages-a preoperative gastric endoscopy was performed. The endoscopy identified multiple faded mucosal lesions, which biopsy confirmed as signet-ring cell carcinoma. The patient subsequently underwent total gastrectomy and gallbladder bed resection. Postoperative pathology identified 22 distinct malignant gastric lesions, predominantly signet-ring cell carcinoma (pT1a), showing variable or lost E-cadherin expression. Germline genetic testing

conclusionThis represents the first reported case of synchronous HDGC and primary gallbladder adenocarcinoma associated with a germline

Indexed as

AdenocarcinomaAntigens, CDCadherinsGallbladder NeoplasmsGerm-Line MutationStomach NeoplasmsAgedCarcinogenesisCarcinoma, Signet Ring CellFemaleGenetic Predisposition to DiseaseHumansPedigreeAntigens, CDCadherinsCDH1 protein, humanCDH1 mutationgallbladder cancerHereditary diffuse gastric cancer

Identifiers

PMID42665410
PMCPMC13531147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.